Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Point-of-care fluorescence immunoassay for prostate specific antigen.

Oh SW, Kim YM, Kim HJ, Kim SJ, Cho JS, Choi EY.

Clin Chim Acta. 2009 Aug;406(1-2):18-22. doi: 10.1016/j.cca.2009.04.013. Epub 2009 Apr 23.

PMID:
19393638
2.

Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood.

Ahn JS, Choi S, Jang SH, Chang HJ, Kim JH, Nahm KB, Oh SW, Choi EY.

Clin Chim Acta. 2003 Jun;332(1-2):51-9.

PMID:
12763280
3.

A rapid, simple measurement of human albumin in whole blood using a fluorescence immunoassay (I).

Choi S, Choi EY, Kim DJ, Kim JH, Kim TS, Oh SW.

Clin Chim Acta. 2004 Jan;339(1-2):147-56.

PMID:
14687905
4.

Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing.

Oh SW, Moon JD, Park SY, Jang HJ, Kim JH, Nahm KB, Choi EY.

Clin Chim Acta. 2005 Jun;356(1-2):172-7. Epub 2005 Mar 31.

PMID:
15936314
5.

One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.

Fernández-Sánchez C, McNeil CJ, Rawson K, Nilsson O, Leung HY, Gnanapragasam V.

J Immunol Methods. 2005 Dec 20;307(1-2):1-12. Epub 2005 Oct 24.

PMID:
16277989
6.

Fluorescence immunoassay of human D-dimer in whole blood.

Kim TK, Oh SW, Mok YJ, Choi EY.

J Clin Lab Anal. 2014 Jul;28(4):294-300. doi: 10.1002/jcla.21683. Epub 2014 Feb 27.

PMID:
24578175
7.

Measurement of alpha-fetoprotein, carcinoembryonic antigen and prostate-specific antigen in serum and heparinised plasma by enzyme immunoassay on the fully automated serono SR1 analyzer.

Cattini R, Cooksey M, Robinson D, Brett G, Bacarese-Hamilton T, Jolley N.

Eur J Clin Chem Clin Biochem. 1993 Aug;31(8):517-24.

PMID:
7692986
8.

Measurement of prostate-specific antigen by use of a novel blood collection and analytical system.

Grzeda BR, Le Bui T, Warner CN, Pirucki TL, Dewey LM, Babich M, Maggiore JA.

Clin Chem. 2002 Aug;48(8):1272-8.

9.
10.

Performance evaluation of a new chemiluminescent assay for prostate specific antigen.

Dasgupta A, Wells A, Datta P.

J Clin Lab Anal. 2000;14(4):164-8.

PMID:
10906769
11.

Point-of-care fluorescence immunoassay for cardiac panel biomarkers.

Kim TK, Oh SW, Hong SC, Mok YJ, Choi EY.

J Clin Lab Anal. 2014 Nov;28(6):419-27. doi: 10.1002/jcla.21704. Epub 2014 Mar 20.

PMID:
24652617
12.

Proximity ligation measurement of the complex between prostate specific antigen and alpha1-protease inhibitor.

Zhu L, Koistinen H, Landegren U, Stenman UH.

Clin Chem. 2009 Sep;55(9):1665-71. doi: 10.1373/clinchem.2009.127779. Epub 2009 Jul 30.

13.
14.

Power-free microchip immunoassay of PSA in human serum for point-of-care testing.

Okada H, Hosokawa K, Maeda M.

Anal Sci. 2011;27(3):237-41.

15.

Point-of-care PSA testing: an evaluation of PSAwatch.

Karim O, Rao A, Emberton M, Cochrane D, Partridge M, Edwards P, Walker I, Davidson I.

Prostate Cancer Prostatic Dis. 2007;10(3):270-3. Epub 2007 Mar 13.

PMID:
17353914
16.

A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen.

Lin YY, Wang J, Liu G, Wu H, Wai CM, Lin Y.

Biosens Bioelectron. 2008 Jun 15;23(11):1659-65. doi: 10.1016/j.bios.2008.01.037. Epub 2008 Feb 21.

PMID:
18406127
17.

Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination.

Haltmayer M, Mueller T, Gegenhuber A, Poelz W.

Clin Lab. 2004;50(3-4):175-80.

PMID:
15074472
18.

Homogeneous dual-parameter assay for prostate-specific antigen based on fluorescence resonance energy transfer.

Kokko T, Liljenbäck T, Peltola MT, Kokko L, Soukka T.

Anal Chem. 2008 Dec 15;80(24):9763-8. doi: 10.1021/ac801875a.

PMID:
19012418
19.

An ultrasensitive immunoassay for prostate-specific antigen based on conventional colorimetric detection.

Khosravi MJ, Papanastasiou-Diamandi A, Mistry J.

Clin Biochem. 1995 Aug;28(4):407-14.

PMID:
8521595
20.

Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology.

Soukka T, Antonen K, Härmä H, Pelkkikangas AM, Huhtinen P, Lövgren T.

Clin Chim Acta. 2003 Feb;328(1-2):45-58.

PMID:
12559598

Supplemental Content

Support Center